Cloning a Chow Chow will be easy and will also cost at least half of what it would cost to clone any other type of dog, announced a South Korean biotech company today while presenting new cloning technology.
But dog-owners – who pay 100,000 dollars or more to clone a pet – will still have to pay tens of thousands of dollars if they want to clone their beloved four-legged friends, and must be prepared for long waiting-lists, because most cloning at a commercial level involves dogs used for work, like police dogs used in airports.
The Rnl Bio company announced
Stem Cell Research Brings About Another Miracle
Korean doctors have apparently regrown a patient’s jawbone using the patient’s own Adult Stem Cells in yet another amazing miracle that Adult Stem Cell research has brought us.
An 18 year old Korean boy who had to have most of his jawbone and his teeth removed due to a tumor […]
University at Buffalo researchers will test the effectiveness of using stem cells from donors to treat patients with heart failure.
The National Heart, Lung and Blood Institute has awarded $2 million for the four-year translational animal study.
The results could pave the way for a similar trial in humans and eventually help make stem cell therapy more widely available (…)
Stem cells that could restore sight and hearing have been discovered in an experiment that has been performed successfully in animals. But according to two teams of scientists, it is an important step which will lead to future applications in humans.
A team from the Chonnam National University of South Korea was able to restore hearing in guinea pigs whose hearing was destroyed by chemical substances, using mesenchymal stem cells taken from human bone marrow. Other researchers at SUNY Upstate Medical University of Syracuse in the United States were able to restore sight in frogs using skin stem
Image by erjkprunczyk via Flickr
After the decision of the United States to remove the ban preventing stem cell researchers from using public funding for experiments, legislators in South Korea have been put under pressure by scientists who have been aspiring to do experiments on stem cells from cloned human embryos.
Up until a few weeks ago the National Bioethics Committee continued to postpone a decision on the matter, but now thanks to the American president, it is increasingly probable that at most, by the end of April, researchers of the Cha Medical Institute of Seoul will be able to resume